Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Result of AGM

18 Jun 2019 17:27

RNS Number : 6753C
Ceiba Investments Limited
18 June 2019
 

 

18 June 2019

CEIBA INVESTMENTS LIMITED

(the "Company")

 

(TICKER CBA, ISIN: GG00BFMDJH11)

 

 

RESULTS OF ANNUAL GENERAL MEETING

 

 

In accordance with the provisions of E.2.2 of The UK Corporate Governance Code, the Company advises that 

for the Annual General Meeting held on 18 June 2019 valid proxy appointments were made in respect of

79,899,827 of the total redeemable ordinary shares of the Company in issue, being 137,671,576.

 

Voting was as follows:

 

1. IT WAS RESOLVED to receive the Annual Financial Report of the Company for the year ended 31 December 2018. (79,899,827 votes cast, all in favour, none against and none withheld).

 

2. IT WAS RESOLVED to re-appoint Ernst & Young as Auditor of the Company, to hold office from the conclusion of this meeting until the conclusion of the next annual general meeting. (79,899,827 votes cast, all in favour, none against and none withheld).

 

3. IT WAS RESOLVED that the Directors be authorised to fix the remuneration of the Company's Auditors. (79,899,827 votes cast, all in favour, none against and none withheld).

 

4. IT WAS RESOLVED to ratify the cash dividend in the amount of USD0.0625 per Share declared on 30 April 2019 (and paid to Shareholders on 14 June 2019). (79,899,827 votes cast, all in favour, none against and none withheld).

 

5. IT WAS RESOLVED to re-appoint John Herring as a Director of the Company, to hold office until the conclusion of the next Annual General Meeting of the Company. (79,899,827 votes cast, all in favour, none against and none withheld).

 

6. IT WAS RESOLVED to appoint Trevor Bowen as a Director of the Company, to hold office until the conclusion of the next Annual General Meeting of the Company. (79,899,827 votes cast, all in favour, none against and none withheld).

 

7. IT WAS RESOLVED to appoint Keith Corbin as a Director of the Company, to hold office until the conclusion of the next Annual General Meeting of the Company. (79,899,827 votes cast, all in favour, none against and none withheld).

 

8. IT WAS RESOLVED to appoint Peter Cornell as a Director of the Company, to hold office until the conclusion of the next Annual General Meeting of the Company. (79,899,827 votes cast, all in favour, none against and none withheld).

 

9. IT WAS RESOLVED to re-appoint Colin Kingsnorth as a Director of the Company, to hold office until the conclusion of the next Annual General Meeting of the Company. (79,899,827 votes cast, all in favour, none against and none withheld).

 

10. IT WAS RESOLVED to authorise the Company in accordance with section 315 of the Companies (Guernsey) Law, 2008 (as amended) (the "Law") to make one or more market acquisitions (as defined in the Law) of its own Ordinary Shares either for cancellation or to hold as treasury shares for future resale or transfer on the terms set out in the notice of the AGM. (79,899,827 votes cast, all in favour, none against and none withheld).

 

Following the reference in the Chairman's Statement in the Company's Annual Report to 31 December 2018, the Board announces that John Herring will continue to serve as the Company's Chairman. The Board regularly reviews composition of the Board and succession planning and the independent Directors have resolved that, given the projects currently underway at the Company, John's continued appointment is in the best interests of the shareholders as a whole.

 

The Board also announces that Colin Kingsnorth has stepped down from the Audit Committee and the Nomination Committee with effect from 10 June 2019. 

 

For further information, please contact:

 

Aberdeen Standard Fund Managers Limited

Sebastiaan Berger / Gary Jones / Christian Pittard

 

Tel: +44 (0)20 7463 6000

N+1 Singer

James Maxwell / James Moat (Corporate Finance)

James Waterlow (Sales)

 

Tel: +44 (0)20 7496 3000

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGSFLFMAFUSEEM
12
Date   Source Headline
5th Jun 20268:33 amRNSTrading Update
27th May 20263:39 pmRNSHolding(s) in Company
22nd May 20262:30 pmRNSHolding(s) in Company
20th May 20263:37 pmRNSHolding(s) in Company
19th May 20261:07 pmRNSHolding(s) in Company
15th May 202612:40 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSIssue of Equity
30th Apr 20267:00 amRNSAnnual Financial Report
14th Apr 20264:46 pmRNSResult of EGM
1st Apr 202611:21 amRNSFurther re Second Amendment of Bond Instrument
27th Feb 20265:14 pmRNSFurther re Second Amendment of Bond Instrument
27th Feb 20262:26 pmRNSDirectorate change
13th Feb 20265:13 pmRNSStatement re Second Amendment of Bond Instrument
13th Feb 20263:20 pmRNSDirector Declaration
12th Feb 20265:32 pmRNSChange of Auditor
5th Feb 20267:00 amRNSTrading Update - Consultation with Bondholders
26th Jan 20263:36 pmRNSDirector/PDMR Shareholding
23rd Dec 20251:39 pmRNSNet Asset Value(s)
4th Dec 20253:25 pmRNSAppointment of Senior Independent Director
2nd Oct 20252:48 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSHalf-year Report
12th Sep 20253:16 pmRNSDirectorate Change
8th Jul 20257:00 amRNSTrading Update - Payment to Bondholders
4th Jul 202512:49 pmRNSDirectorate Change
3rd Jul 20253:14 pmRNSResult of AGM
1st Jul 20251:35 pmRNSNet Asset Value(s)
30th Apr 20257:00 amRNSAnnual Financial Report
28th Apr 202510:26 amRNSDirectorate Change
3rd Feb 20257:00 amRNSStatement re Amendment of Bond Instrument
13th Jan 20255:51 pmRNSStatement re Amendment of Bond Instrument
11th Dec 20241:31 pmRNSNet Asset Value(s)
7th Oct 202410:55 amRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSStatement re Update from the Chairman
27th Sep 20247:00 amRNSHalf-year Report to 30 June 2024
13th Aug 20248:36 amRNSDirectorate Change
20th Jun 20243:09 pmRNSDirector/PDMR Shareholding
20th Jun 20247:00 amRNSNet Asset Value(s)
18th Jun 20244:53 pmRNSResult of AGM
30th Apr 20247:00 amRNSAnnual Financial Report
25th Mar 202411:03 amRNSDirectorate Change
17th Jan 20247:00 amRNSInvestment Update
27th Dec 20239:17 amRNSNet Asset Value(s)
18th Dec 20238:54 amRNSDirector/PDMR Shareholding
3rd Nov 202310:36 amRNSHolding(s) in Company
1st Nov 20239:05 amRNSDirector/PDMR Shareholding
27th Oct 202311:11 amRNSDirector/PDMR Shareholding
16th Oct 20238:37 amRNSAppointment of Non-Executive Director
12th Oct 20234:26 pmRNSDirector/PDMR Shareholding
5th Oct 202310:24 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.